HEMOSENSE
HemoSense manufactures handheld blood coagulation monitoring systems for the management of warfarin medications for patients and healthcare professionals. It offers INRatio System that measures the patient's blood clotting time to ensure that patients with a propensity to form clots are maintained within the therapeutic range with the proper dosage of oral anticoagulant therapy. The company offers its products through distributor partners. HemoSense, Inc. was formerly known as CardioSense, Inc. and changed its name to HemoSense, Inc. in January 1998. It was founded in 1997 and is based in San Jose, California. As of November 6, 2007, HemoSense, Inc. operates as a subsidiary of Alere Inc.
HEMOSENSE
Industry:
Health Care Manufacturing
Founded:
1997-01-01
Address:
San Jose, California, United States
Country:
United States
Status:
Active
Total Funding:
7 M USD
Similar Organizations
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Meissner
Meissner manufactures advanced microfiltration products and One-Touch® single-use systems for critical applications.
Current Employees Featured
Stock Details
Investors List
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - HemoSense